The Effects of Transient Dopamine Antagonism on Thyrotropin-Releasing Hormone-Induced Prolactin Release in Pseudopregnant Rats*
- 1 November 1986
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 119 (5) , 1989-1995
- https://doi.org/10.1210/endo-119-5-1989
Abstract
The effectiveness of TRH in releasing PRL after transient doapmine (DA) blockade was investigated in female rats between days 3 and 11 of pseudopregnancy (PSP). At 0930 h on the morning of the experiment, each animal was injected with the DA antagonist domperidone (0.01 mg/rat, iv) or vehicle (acetic acid in saline); 5 min later, the DA agonist 2-bromo-.alpha.-ergocryptine maeleate (CB-154; 0.5 mg/rat, iv) was administered. Sixty minutes later, TRH (1.0 .mu.g/rat, iv) was administered. Blood samples were withdrawn via indwelling catheters before, 5, 20, 40, and 70 min after domperidone or vehicle administration, and 5 and 10 min after TRH administration. On day 3 of PSP, TRH-induced PRL release was significantly enhanced by the domperidone-CB154 treatment compared to that in vehicle-treated control rats. By day 9 of PSP, the effectiveness of TRH in stimulating PRL release after domperidone treatment was decreased by 50% compared to that on day 3 of PSP. This reduction in PRL response to TRH was not due to decreased progesterone levels, as no difference was observed in plasma progesterone between days 3 and 9. Rates that were given domperidone on day 11 of PSP did not exhibit a significant increase in sensitivity to TRH: however, the effectiveness of TRH was enhanced by domperidone on day 11 of PSP in animals that were hysterectomized on day 2 of PSP. Since DA receptor blockade increased the sensitivity to a putative PRL-releasing factor (TRH) and this mechanism was eliminated around the time that the PRL surges of PSP disappear, we suggest that this pituitary mechanism is a critical component of the PRL release mechanism during the surges of PSP. Further, the observed loss of the mechanism between days 9 and 11 of PSP may be due to the direct influence at the anterior pituitary of a uterine PRL inhibitory factor which has been recently described.This publication has 27 references indexed in Scilit:
- The Effect of Transient Dopamine Antagonism on Thyrotropin-Releasing Hormone-Induced Prolactin Release in Ovariectomized Rats Treated with Estradiol and/or Progesterone*Endocrinology, 1986
- A Direct Effect of the Uterus on the Surges of Prolactin Induced by Cervical Stimulation in the Rat*Endocrinology, 1979
- EVIDENCE FOR A RAPID INVIVO EFFECT ON ESTRADIOL-17-BETA ON PROLACTIN SECRETION IN OVARIECTOMIZED RATS1979
- Mammary Arterial and Venous Concentrations of Prolactin in Lactating Cows after Milking or Administration of Thyrotropin-Releasing Hormone or Ergocryptine*Endocrinology, 1979
- Prolactin Release by Vasoactive Intestinal Polypeptide in Rats*Endocrinology, 1978
- Potent Antidopaminergic Activity of Estradiol at the Pituitary Level on Prolactin ReleaseScience, 1978
- Ovarian Steroid Modulation of Prolactin Surges in Cervically Stimulated Ovariectomized Rats*Endocrinology, 1978
- Dopamine Levels in Hypophysial Stalk Blood in the Rat are Sufficient to Inhibit Prolactin SecretionIn Vivo*Endocrinology, 1978
- SUPPRESSION OF PROLACTIN AND THYROTROPIN SECRETION IN THE RAT BY ANTISERUM TO THYROTROPIN-RELEASING HORMONEEndocrinology, 1977
- Prolactin: The Initial Luteotropic Stimulus of Pseudopregnancy in the RatEndocrinology, 1976